NCT07810322 Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina
| NCT ID | NCT07810322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Opioid Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-07-29 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-07-29 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will evaluate the emPath digital platform, a platform designed to improve access to and retention in low-barrier telemedicine for delivery of medication for opioid use disorder (MOUD) among adults with opioid use disorder who engage with community outreach programs in Durham, North Carolina.
Eligibility Criteria
Inclusion Criteria for Outreach program PWOUD (n=50): * Age 18 or older * Screen positive for moderate to high risk opioid use by WHO-ASSIST * Not currently prescribed any form of MOUD * Able to speak and understand English * Able and willing to provide informed consent Inclusion Criteria for Outreach Staff (n=10): * Age 18 or older * Employed by the preceding 1 month or longer at time of enrollment * Able and willing to provide informed consent
Contact & Investigator
Jacqueline Hodges, MD MPH
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT07810322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07810322 currently recruiting?
Yes, NCT07810322 is actively recruiting participants. Contact the research team at jacqueline.hodges@duke.edu for enrollment information.
Where is the NCT07810322 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07810322 clinical trial?
NCT07810322 is sponsored by Duke University. The principal investigator is Jacqueline Hodges, MD MPH at Duke University. The trial plans to enroll 80 participants.